Home / Next Generation Sequencing (NGS) Reagent Kits / Document

GenDx Reagents Statement of Work FY26

Updated

A Word document (23 KB) attached to Next Generation Sequencing (NGS) Reagent Kits, from the Department of Veterans Affairs. Due Nov 22, 2026, 1:00 PM (UTC-6).

File name: P09 GenDx Reagents SOW FY26.docx

Download the full documentSee the bid

The full file is for paid members, or buy this bid alone.

Preview

?.## STATEMENT OF WORK

GenDx NGS Reagents

GENERAL INFORMATION

The Contractor shall provide next generation sequencing (NGS) reagent kits compatible with the Illumina MiSeq instrument. All reagents must meet the performance characteristics for accuracy and precision as defined by the Clinical Laboratory Improvement Act (CLIA) and the Clinical and Laboratory Standards Institute (CLSI). Goods shall be purchased on an as-needed basis by the Iowa City VA Health Care System, 601 Highway 6 West, Iowa City, IA 52246, Immunology Department of Pathology and Laboratory Medicine. This is a firm, fixed price, Indefinite Delivery-Indefinite Quantity (IDIQ) contract.

REAGENT SPECIFICATIONS

Contractor must supply NGS reagent kits used to perform identification of human leukocyte antigen alleles through amplification of A, B, C, DPA1, DPB1, DQA1, DQB1, DRB1, DRB3/4/5.

No product substitutions will be accepted without prior approval of the VA Health Care System Laboratory Service Contracting Officer Representative (COR) or designee. Catalog #2342256 IndX plate II, #2342356 IndX plate III, and #2342456 IndX plate IV can freely be substituted for #2342156 IndX plate I.

All products purchases are subject to acceptance by the COR or designee. Products that fail to meet quality and control criteria will not be accepted. Products will be rejected, discarded, or returned to the Contractor at the Contractor’s expense if found to be unsatisfactory at time of receipt, or, due to product deterioration prior to outdate. The Iowa City VA will not be financially liable for unacceptable materials.

All products must be tested for quality control by the manufacturer. Only products that pass inspection will be sent to Iowa City VA. The Contractor will demonstrate documentation of quality control performance on any item upon request by the COR designee, including Certificate of Analysis, Analytical Standard Certificates of Quality, and/or Chemical Data Sheets.

All defective or inferior products must be replaced within 48 business hours at no cost to the Iowa City VA.

The Contractor will immediately notify the Contracting Officer and Iowa City VA COR of any recalls of products or other important product safety issues. As appropriate, the Contractor will replace and/or reimburse recalled/defective products at no cost to the Iowa City VA. The Contractor will be liable for all costs of processing recalls.

TRANSITION

The Contractor shall be responsible for all costs associated with the validation of new reagent kits for next generation sequencing (NGS) platforms. This includes, without limitation, analytical validation studies, reagent lot-to-lot verification, materials and consumables, instrument time, personnel labor, data analysis, documentation, and any third party testing required to meet the applicable regulatory and quality requirements. The Government shall bear no direct or indirect cost for validation activities unless expressly agreed to in writing through a contract modification.

The beginning of the document. Download the full file to read on.

Other documents in this bid